{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:42:30Z","timestamp":1789400550789,"version":"build-2803163510"},"reference-count":114,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.hoc.2007.06.001","type":"journal-article","created":{"date-parts":[[2007,7,31]],"date-time":"2007-07-31T07:27:28Z","timestamp":1185866848000},"page":"647-661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Acquired Platelet Dysfunction"],"prefix":"10.1016","volume":"21","author":[{"given":"Yu-Min P.","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene P.","family":"Frenkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.hoc.2007.06.001_bib1","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1172\/JCI114904","article-title":"Role of endothelium-derived nitric oxide in the bleeding tendency of uremia","volume":"86","author":"Remuzzi","year":"1990","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.hoc.2007.06.001_bib2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/ki.1993.264","article-title":"Enhanced nitric oxide synthesis in uremia: implications for platelet dysfunction and dialysis hypotension","volume":"44","author":"Noris","year":"1993","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.hoc.2007.06.001_bib3","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1182\/blood.V76.7.1336.1336","article-title":"Uremic platelets have a functional defect affecting the interaction of von Willebrand factor with glycoprotein IIb-IIIa","volume":"76","author":"Escolar","year":"1990","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2007.06.001_bib4","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0002-9343(88)80025-1","article-title":"Plasma and platelet von Willebrand factor defects in uremia","volume":"85","author":"Gralnick","year":"1988","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.hoc.2007.06.001_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/039139880102400303","article-title":"Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis","volume":"24","author":"Salvati","year":"2001","journal-title":"Int J Artif Organs"},{"issue":"4","key":"10.1016\/j.hoc.2007.06.001_bib6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2141.1995.tb08425.x","article-title":"Impaired high-shear-stress-induced platelet aggregation in patients with chronic renal failure undergoing haemodialysis","volume":"89","author":"Yoshida","year":"1995","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.hoc.2007.06.001_bib7","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/0002-9343(85)90051-8","article-title":"Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis","volume":"79","author":"Di Minno","year":"1985","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.hoc.2007.06.001_bib8","first-page":"823","article-title":"Abnormal cytoskeletal assembly in platelets from uremic patients","volume":"143","author":"Escolar","year":"1993","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.hoc.2007.06.001_bib9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2362.1982.tb00683.x","article-title":"Adenylate cyclase activity and cAMP content of human platelets in uraemia","volume":"12","author":"Vlachoyannis","year":"1982","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"10.1016\/j.hoc.2007.06.001_bib10","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0272-6386(95)90123-X","article-title":"Defective platelet aggregation in uremia is transiently worsened by hemodialysis","volume":"25","author":"Sreedhara","year":"1995","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.hoc.2007.06.001_bib11","first-page":"2244","article-title":"Correction of uremic platelet dysfunction after renal transplantation","volume":"27","author":"Campistol","year":"1995","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1016\/j.hoc.2007.06.001_bib12","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ki.1992.333","article-title":"Recombinant human erythropoietin treatment improves platelet function in uremic patients","volume":"42","author":"Cases","year":"1992","journal-title":"Kidney Int"},{"issue":"8570","key":"10.1016\/j.hoc.2007.06.001_bib13","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0140-6736(87)91849-6","article-title":"Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietin","volume":"2","author":"Moia","year":"1987","journal-title":"Lancet"},{"issue":"6724","key":"10.1016\/j.hoc.2007.06.001_bib14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/bmj.300.6724.573","article-title":"Canadian Erythropoietin Study Group. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group","volume":"300","year":"1990","journal-title":"BMJ"},{"issue":"23","key":"10.1016\/j.hoc.2007.06.001_bib15","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJM198012043032302","article-title":"Treatment of the bleeding tendency in uremia with cryoprecipitate","volume":"303","author":"Janson","year":"1980","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.hoc.2007.06.001_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM198301063080102","article-title":"Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia","volume":"308","author":"Mannucci","year":"1983","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.hoc.2007.06.001_bib17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ajh.2830390204","article-title":"Desmopressin (d-DAVP) effects on platelet rheology and von Willebrand factor activities in uremia","volume":"39","author":"Zeigler","year":"1992","journal-title":"Am J Hematol"},{"issue":"12","key":"10.1016\/j.hoc.2007.06.001_bib18","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJM198609183151204","article-title":"Conjugated estrogens for the management of bleeding associated with renal failure","volume":"315","author":"Livio","year":"1986","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.hoc.2007.06.001_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ajh.2830460105","article-title":"Perioperative administration of a single dose of conjugated oestrogen to uraemic patients is ineffective in improving haemostasis","volume":"46","author":"Jacobs","year":"1994","journal-title":"Am J Hematol"},{"issue":"24","key":"10.1016\/j.hoc.2007.06.001_bib20","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJM196706152762403","article-title":"Platelet aggregation in patients with Laennec's cirrhosis of the liver","volume":"276","author":"Thomas","year":"1967","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.hoc.2007.06.001_bib21","first-page":"137","article-title":"Effect of alcoholism on hemostasis","volume":"17","author":"Cowan","year":"1980","journal-title":"Semin Hematol"},{"issue":"4","key":"10.1016\/j.hoc.2007.06.001_bib22","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0272-2712(18)30355-X","article-title":"Coagulopathies of liver disease","volume":"14","author":"Mammen","year":"1994","journal-title":"Clin Lab Med"},{"issue":"4","key":"10.1016\/j.hoc.2007.06.001_bib23","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1182\/blood.V67.4.1148.1148","article-title":"Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time","volume":"67","author":"Mannucci","year":"1986","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2007.06.001_bib24","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00000441-199312000-00001","article-title":"Hemostatic abnormalities associated with monoclonal gammopathies","volume":"306","author":"Robert","year":"1993","journal-title":"Am J Med Sci"},{"issue":"1\u20132","key":"10.1016\/j.hoc.2007.06.001_bib25","first-page":"202","article-title":"Platelet aggregation in Waldenstrom's macroglobulinaemia","volume":"14","author":"Rozenberg","year":"1965","journal-title":"Thromb Diath Haemorrh"},{"issue":"5","key":"10.1016\/j.hoc.2007.06.001_bib26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000206411","article-title":"Hemorrhagic diathesis in multiple myeloma","volume":"72","author":"Wallace","year":"1984","journal-title":"Acta Haematol"},{"issue":"6","key":"10.1016\/j.hoc.2007.06.001_bib27","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1182\/blood.V29.6.823.823","article-title":"Bleeding syndrome in a patient with IgA myeloma: interaction of protein and connective tissue","volume":"29","author":"Vigliano","year":"1967","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2007.06.001_bib28","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2141.1979.tb01171.x","article-title":"Correlation between serum IgG, platelet membrane IgG, and platelet function in hypergammaglobulinaemic states","volume":"42","author":"McGrath","year":"1979","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2007.06.001_bib29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1172\/JCI112270","article-title":"A myeloma paraprotein with specificity for platelet glycoprotein IIIa in a patient with a fatal bleeding disorder","volume":"77","author":"DiMinno","year":"1986","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.hoc.2007.06.001_bib30","first-page":"432","article-title":"Abnormal platelet function in myeloproliferative disorders","volume":"105","author":"Waddell","year":"1981","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.hoc.2007.06.001_bib31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-0609.1983.tb00634.x","article-title":"Megakaryocytes in cubital venous blood in patients with chronic myeloproliferative diseases","volume":"30","author":"Tinggaard Pedersen","year":"1983","journal-title":"Scand J Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2007.06.001_bib32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2141.1988.tb04185.x","article-title":"An acquired Bernard-Soulier-like platelet defect associated with juvenile myelodysplastic syndrome","volume":"68","author":"Berndt","year":"1988","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.hoc.2007.06.001_bib33","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-0038-1661099","article-title":"Abnormal platelet serotonin uptake and binding sites in myeloproliferative disorders","volume":"51","author":"Caranobe","year":"1984","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.hoc.2007.06.001_bib34","first-page":"954","article-title":"Combined defect in membrane expression and activation of platelet GPIIb\u2013IIIa complex without primary sequence abnormalities in myeloproliferative disease","volume":"111","author":"Kaplan","year":"2000","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.hoc.2007.06.001_bib35","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1172\/JCI110118","article-title":"Platelet Fc receptor. Increased expression in myeloproliferative disease","volume":"67","author":"Moore","year":"1981","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.hoc.2007.06.001_bib36","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2141.1982.tb02804.x","article-title":"Subnormal platelet response to thromboxane A2 in a patient with chronic myeloid leukaemia","volume":"51","author":"Okuma","year":"1982","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.hoc.2007.06.001_bib37","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0262-1746(83)90004-5","article-title":"Altered arachidonate metabolism by leukocytes and platelets in myeloproliferative disorders","volume":"12","author":"Takayama","year":"1983","journal-title":"Prostaglandins Leukot Med"},{"issue":"3","key":"10.1016\/j.hoc.2007.06.001_bib38","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0609.1981.tb01391.x","article-title":"Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests","volume":"25","author":"Boneu","year":"1980","journal-title":"Scand J Haematol"},{"issue":"2","key":"10.1016\/j.hoc.2007.06.001_bib39","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1055\/s-0038-1645964","article-title":"Abnormal structure of von Willebrand factor in myeloproliferative syndrome is associated to either thrombotic or bleeding diathesis","volume":"58","author":"Lopez-Fernandez","year":"1987","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.hoc.2007.06.001_bib40","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ajh.2830440409","article-title":"Multimeric pattern of plasma and platelet von Willebrand factor is normal in uremic patients","volume":"44","author":"Castaman","year":"1993","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.hoc.2007.06.001_bib41","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1182\/blood.V68.6.1213.1213","article-title":"Subunit composition of plasma von Willebrand factor in patients with the myeloproliferative syndrome","volume":"68","author":"Budde","year":"1986","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.hoc.2007.06.001_bib42","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1046\/j.1365-2141.1999.01399.x","article-title":"Thrombosis and bleeding in myeloproliferative disorders: identification of at-risk patients with whole blood platelet aggregation studies","volume":"105","author":"Manoharan","year":"1999","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.hoc.2007.06.001_bib43","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/jcp.44.4.300","article-title":"Dysmegakaryopoiesis in myelodysplastic syndromes (MDS): an immunomorphometric study of bone marrow trephine biopsy specimens","volume":"44","author":"Thiele","year":"1991","journal-title":"J Clin Pathol"},{"issue":"4","key":"10.1016\/j.hoc.2007.06.001_bib44","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2141.1991.tb08618.x","article-title":"Are \u2018dysplastic\u2019 and hypogranular megakaryocytes specific markers for myelodysplastic syndrome?","volume":"77","author":"Wong","year":"1991","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.hoc.2007.06.001_bib45","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0145-2126(87)90012-9","article-title":"Balloon-like platelets in myelodysplastic syndromes\u2013a feature of dysmegakaryopoiesis?","volume":"11","author":"Widell","year":"1987","journal-title":"Leuk Res"},{"issue":"4\u20135","key":"10.1016\/j.hoc.2007.06.001_bib46","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/10428199209051007","article-title":"Platelet storage pool deficiency, leukemia, and myelodysplastic syndromes","volume":"8","author":"Gerrard","year":"1992","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.hoc.2007.06.001_bib47","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1600-0609.1984.tb00730.x","article-title":"The myelodysplastic syndromes\u2013a study of haemostatic function and platelet ultrastructure","volume":"33","author":"Pamphilon","year":"1984","journal-title":"Scand J Haematol"},{"key":"10.1016\/j.hoc.2007.06.001_bib48","first-page":"97","article-title":"Platelet IgG: measurement, interpretation, and clinical significance","volume":"10","author":"George","year":"1991","journal-title":"Prog Hemost Thromb"},{"issue":"2","key":"10.1016\/j.hoc.2007.06.001_bib49","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1182\/blood.V58.2.326.326","article-title":"Abnormal platelet function and arachidonate metabolism in chronic idiopathic thrombocytopenic purpura","volume":"58","author":"Stuart","year":"1981","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.hoc.2007.06.001_bib50","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJM199411033311807","article-title":"Chronic idiopathic thrombocytopenic purpura","volume":"331","author":"George","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.hoc.2007.06.001_bib51","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1182\/blood.V70.2.428.428","article-title":"Pseudo-Bernard-Soulier syndrome: thrombocytopenia caused by autoantibody to platelet glycoprotein Ib","volume":"70","author":"Devine","year":"1987","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2007.06.001_bib52","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00282-996-0355-7","article-title":"Lack of platelet response to collagen associated with autoantibodies against glycoprotein (GP) Ia\/IIa and Ib\/IX leading to the discovery of SLE","volume":"38","author":"Dromigny","year":"1996","journal-title":"Hematol Cell Ther"},{"issue":"8","key":"10.1016\/j.hoc.2007.06.001_bib53","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/art.1780250809","article-title":"Mechanisms of abnormal platelet aggregation in systemic lupus erythematosus","volume":"25","author":"Dorsch","year":"1982","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.hoc.2007.06.001_bib54","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1136\/jcp.31.12.1239","article-title":"Platelet aggregation in chronic idiopathic thrombocytopenic purpura","volume":"31","author":"Heyns","year":"1978","journal-title":"J Clin Pathol"},{"issue":"3","key":"10.1016\/j.hoc.2007.06.001_bib55","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1073\/pnas.84.3.861","article-title":"Incorporation of a circulating protein into megakaryocyte and platelet granules","volume":"84","author":"Handagama","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.hoc.2007.06.001_bib56","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0002-9343(80)90436-2","article-title":"Acquired storage pool deficiency with increased platelet-associated IgG. Report of five cases","volume":"69","author":"Weiss","year":"1980","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.hoc.2007.06.001_bib57","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0002-9343(80)90383-6","article-title":"Acquired dysfunction due to the circulation of \u201cexhausted\u201d platelets","volume":"69","author":"Pareti","year":"1980","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.hoc.2007.06.001_bib58","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2141.1973.tb01668.x","article-title":"A quantitative evaluation of the inhibition of platelet aggregation by low molecular weight degradation products of fibrinogen","volume":"24","author":"Solum","year":"1973","journal-title":"Br J\u00a0Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2007.06.001_bib59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood.V52.1.13.13","article-title":"Acquired decrease in platelet secretory ADP associated with increased postoperative bleeding in post-cardiopulmonary bypass patients and in patients with severe valvular heart disease","volume":"52","author":"Beurling-Harbury","year":"1978","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2007.06.001_bib60","first-page":"824","article-title":"Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release","volume":"56","author":"Harker","year":"1980","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2007.06.001_bib61","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0022-5223(19)34841-X","article-title":"Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss","volume":"104","author":"Khuri","year":"1992","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.hoc.2007.06.001_bib62","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0022-5223(19)40355-3","article-title":"The hemostatic mechanism after open-heart surgery. II. Frequency of abnormal platelet functions during and after extracorporeal circulation","volume":"70","author":"McKenna","year":"1975","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"9","key":"10.1016\/j.hoc.2007.06.001_bib63","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1182\/blood.V76.9.1680.1680","article-title":"Bleeding complications associated with cardiopulmonary bypass","volume":"76","author":"Woodman","year":"1990","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2007.06.001_bib64","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1182\/blood.V75.1.128.128","article-title":"Direct detection of activated platelets and platelet-derived microparticles in humans","volume":"75","author":"Abrams","year":"1990","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2007.06.001_bib65","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI112582","article-title":"Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery","volume":"78","author":"George","year":"1986","journal-title":"J\u00a0Clin Invest"},{"issue":"3 Pt 2","key":"10.1016\/j.hoc.2007.06.001_bib66","first-page":"H615","article-title":"Fibrinogen receptors in platelet adhesion to surfaces of extracorporeal circuit","volume":"252","author":"Gluszko","year":"1987","journal-title":"Am J Physiol"},{"issue":"2","key":"10.1016\/j.hoc.2007.06.001_bib67","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1182\/blood.V68.2.355.355","article-title":"Does the conformation of adsorbed fibrinogen dictate platelet interactions with artificial surfaces?","volume":"68","author":"Lindon","year":"1986","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2007.06.001_bib68","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1182\/blood.V82.1.107.bloodjournal821107","article-title":"The platelet function defect of cardiopulmonary bypass","volume":"82","author":"Kestin","year":"1993","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2007.06.001_bib69","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/0003-4975(95)00668-B","article-title":"Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass","volume":"60","author":"Khuri","year":"1995","journal-title":"Ann Thorac Surg"},{"issue":"14","key":"10.1016\/j.hoc.2007.06.001_bib70","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJM198304073081402","article-title":"Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients","volume":"308","author":"Weksler","year":"1983","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.hoc.2007.06.001_bib71","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM198911233212104","article-title":"A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery","volume":"321","author":"Hackmann","year":"1989","journal-title":"N Engl J\u00a0Med"},{"issue":"2","key":"10.1016\/j.hoc.2007.06.001_bib72","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0022-5223(19)34413-7","article-title":"The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children","volume":"98","author":"Seear","year":"1989","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.hoc.2007.06.001_bib73","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0022-5223(19)36060-X","article-title":"A prospective, randomized study of the effects of prostacyclin on platelets and blood loss during coronary bypass operations","volume":"91","author":"Fish","year":"1986","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.hoc.2007.06.001_bib74","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2141.1981.tb07244.x","article-title":"A double blind study of prostacyclin in cardiopulmonary bypass surgery","volume":"49","author":"Walker","year":"1981","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.hoc.2007.06.001_bib75","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF03009046","article-title":"Natural and synthetic antifibrinolytics in cardiac surgery","volume":"39","author":"Hardy","year":"1992","journal-title":"Can J\u00a0Anaesth"},{"issue":"5","key":"10.1016\/j.hoc.2007.06.001_bib76","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0022-5223(19)36893-X","article-title":"Aprotinin protects platelets against the initial effect of cardiopulmonary bypass","volume":"99","author":"van Oeveren","year":"1990","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.hoc.2007.06.001_bib77","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1172\/JCI108132","article-title":"The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein","volume":"56","author":"Roth","year":"1975","journal-title":"J Clin Invest"},{"issue":"Suppl 4","key":"10.1016\/j.hoc.2007.06.001_bib78","doi-asserted-by":"crossref","first-page":"247S","DOI":"10.1378\/chest.108.4_Supplement.247S","article-title":"Aspirin and other platelet-active drugs. The relationship among dose, effectiveness, and side effects","volume":"108","author":"Hirsh","year":"1995","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.hoc.2007.06.001_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjmed.2006.08.023","article-title":"Aspirin resistance: is it real? Is it clinically significant?","volume":"120","author":"Dalen","year":"2007","journal-title":"Am J Med"},{"issue":"13","key":"10.1016\/j.hoc.2007.06.001_bib80","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJM197509252931301","article-title":"Impaired interaction (adhesion-aggregation) of platelets with the subendothelium in storage-pool disease and after aspirin ingestion. A\u00a0comparison with von Willebrand's disease","volume":"293","author":"Weiss","year":"1975","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.hoc.2007.06.001_bib81","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0609.1984.tb02390.x","article-title":"Effect on platelet aggregation of oral administration of 10 non-steroidal analgesics to humans","volume":"33","author":"Cronberg","year":"1984","journal-title":"Scand J Haematol"},{"issue":"3","key":"10.1016\/j.hoc.2007.06.001_bib82","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2125.1993.tb05689.x","article-title":"The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials","volume":"35","author":"Roderick","year":"1993","journal-title":"Br J Clin Pharmacol"},{"issue":"5B","key":"10.1016\/j.hoc.2007.06.001_bib83","doi-asserted-by":"crossref","first-page":"25S","DOI":"10.1016\/S0002-9343(99)00114-X","article-title":"Effects of nonsteroidal anti-inflammatory therapy on platelets","volume":"106","author":"Schafer","year":"1999","journal-title":"Am J Med"},{"issue":"11","key":"10.1016\/j.hoc.2007.06.001_bib84","first-page":"363","article-title":"Aspirin and surgery\u2013a review","volume":"77","author":"Kennedy","year":"1984","journal-title":"Ir Med J"},{"issue":"8387","key":"10.1016\/j.hoc.2007.06.001_bib85","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(84)91393-X","article-title":"Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders","volume":"1","author":"Kobrinsky","year":"1984","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.hoc.2007.06.001_bib86","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJM198005293022206","article-title":"Nonsteroidal antiinflammatory drugs (second of two parts)","volume":"302","author":"Simon","year":"1980","journal-title":"N Engl J\u00a0Med"},{"issue":"2","key":"10.1016\/j.hoc.2007.06.001_bib87","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/ajh.2830120205","article-title":"Nonsteroidal anti-inflammatory drugs in the treatment of hemophilic arthropathy","volume":"12","author":"Thomas","year":"1982","journal-title":"Am J Hematol"},{"issue":"27","key":"10.1016\/j.hoc.2007.06.001_bib88","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.2174\/1381612033454054","article-title":"Cyclooxygenase-2 biology","volume":"9","author":"Claria","year":"2003","journal-title":"Curr Pharm Des"},{"issue":"2","key":"10.1016\/j.hoc.2007.06.001_bib89","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2165\/00003495-199040020-00006","article-title":"Ticlopidine. An updated review of its pharmacology and therapeutic use in platelet-dependent disorders","volume":"40","author":"McTavish","year":"1990","journal-title":"Drugs"},{"issue":"23","key":"10.1016\/j.hoc.2007.06.001_bib90","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","article-title":"A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators","volume":"339","author":"Leon","year":"1998","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.hoc.2007.06.001_bib91","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-0037-1614427","article-title":"Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation","volume":"81","author":"Jantzen","year":"1999","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.hoc.2007.06.001_bib92","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1055\/s-0038-1647272","article-title":"The action of ticlopidine on human platelets. Studies on aggregation, secretion, calcium mobilization and membrane glycoproteins","volume":"64","author":"Hardisty","year":"1990","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.hoc.2007.06.001_bib93","doi-asserted-by":"crossref","first-page":"924","DOI":"10.7326\/0003-4819-105-6-924","article-title":"Potential for bleeding with the new beta-lactam antibiotics","volume":"105","author":"Sattler","year":"1986","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.hoc.2007.06.001_bib94","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1172\/JCI109676","article-title":"Carbenicillin and penicillin G inhibit platelet function in vitro by impairing the interaction of agonists with the platelet surface","volume":"65","author":"Shattil","year":"1980","journal-title":"J Clin Invest"},{"issue":"Suppl 2","key":"10.1016\/j.hoc.2007.06.001_bib95","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2165\/00003495-198800352-00045","article-title":"Effects of antibiotics on platelet aggregation","volume":"35","author":"Sunakawa","year":"1988","journal-title":"Drugs"},{"issue":"23","key":"10.1016\/j.hoc.2007.06.001_bib96","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1056\/NEJM199506083322306","article-title":"Platelet glycoprotein IIb\/IIIa receptors in cardiovascular medicine","volume":"332","author":"Lefkovits","year":"1995","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.hoc.2007.06.001_bib97","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood.V75.7.1383.1383","article-title":"Glanzmann's thrombasthenia: the spectrum of clinical disease","volume":"75","author":"George","year":"1990","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2007.06.001_bib98","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0735-1097(98)00252-6","article-title":"Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization. Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) Study Group","volume":"32","author":"Berkowitz","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.hoc.2007.06.001_bib99","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S0002-8703(98)70300-X","article-title":"Safe use of platelet GP IIb\/IIIa inhibitors","volume":"135","author":"Ferguson","year":"1998","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.hoc.2007.06.001_bib100","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/blood.V55.4.649.649","article-title":"Inhibition of platelet function by organic nitrate vasodilators","volume":"55","author":"Schafer","year":"1980","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2007.06.001_bib101","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ajh.2830050206","article-title":"Some observations on the in vivo effect of propranolol on platelet aggregation and release","volume":"5","author":"Leon","year":"1978","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.hoc.2007.06.001_bib102","first-page":"H19","article-title":"Interaction of verapamil with human platelet alpha-adrenergic receptors","volume":"242","author":"Barnathan","year":"1982","journal-title":"Am J Physiol"},{"issue":"6","key":"10.1016\/j.hoc.2007.06.001_bib103","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/000331979704800606","article-title":"Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation\/fibrinolysis in patients with coronary artery disease","volume":"48","author":"Fujinishi","year":"1997","journal-title":"Angiology"},{"issue":"3","key":"10.1016\/j.hoc.2007.06.001_bib104","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0049-3848(86)90013-7","article-title":"Effects of oral diltiazem on platelet function: alone and in combination with \u201clow dose\u201d aspirin","volume":"44","author":"Ring","year":"1986","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.hoc.2007.06.001_bib105","first-page":"581","article-title":"Cumulative effects of quinidine and aspirin on bleeding time and platelet alpha 2-adrenoceptors: potential mechanism of bleeding diathesis in patients receiving this combination","volume":"108","author":"Lawson","year":"1986","journal-title":"J Lab Clin Med"},{"issue":"6","key":"10.1016\/j.hoc.2007.06.001_bib106","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/0049-3848(78)90235-9","article-title":"Correlation of inhibition of platelet aggregation by phenothiazines and local anesthetics with their effects on a phospholipid bilayer","volume":"13","author":"Jain","year":"1978","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.hoc.2007.06.001_bib107","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1440-1819.1999.00479.x","article-title":"Different effect of desipramine on protein kinase C in platelets between bipolar and major depressive disorders","volume":"53","author":"Morishita","year":"1999","journal-title":"Psychiatry Clin Neurosci"},{"issue":"7\u20138","key":"10.1016\/j.hoc.2007.06.001_bib108","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1177\/106002809603000716","article-title":"Bruising associated with the use of fluoxetine","volume":"30","author":"Pai","year":"1996","journal-title":"Ann Pharmacother"},{"issue":"9","key":"10.1016\/j.hoc.2007.06.001_bib109","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJM198803033180905","article-title":"Cardiovascular effects of n-3 fatty acids","volume":"318","author":"Leaf","year":"1988","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.hoc.2007.06.001_bib110","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0049-3848(86)90259-8","article-title":"Ajoene, the antiplatelet principle of garlic, synergistically potentiates the antiaggregatory action of prostacyclin, forskolin, indomethacin and dypiridamole on human platelets","volume":"42","author":"Apitz-Castro","year":"1986","journal-title":"Thromb Res"},{"issue":"21","key":"10.1016\/j.hoc.2007.06.001_bib111","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJM198005223022108","article-title":"Szechwan purpura","volume":"302","author":"Hammerschmidt","year":"1980","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.hoc.2007.06.001_bib112","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0262-1746(86)90205-2","article-title":"Onion exerts antiaggregatory effects by altering arachidonic acid metabolism in platelets","volume":"24","author":"Srivastava","year":"1986","journal-title":"Prostaglandins Leukot Med"},{"issue":"1","key":"10.1016\/j.hoc.2007.06.001_bib113","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0952-3278(89)90187-7","article-title":"Extracts from two frequently consumed spices\u2013cumin (Cuminum cyminum) and turmeric (Curcuma longa)\u2013inhibit platelet aggregation and alter eicosanoid biosynthesis in human blood platelets","volume":"37","author":"Srivastava","year":"1989","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"5","key":"10.1016\/j.hoc.2007.06.001_bib114","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/09537109975933","article-title":"Inhibitory effect of Ginkgo biloba extract on human platelet aggregation","volume":"10","year":"1999","journal-title":"Platelets"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985880700072X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985880700072X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:50:41Z","timestamp":1760183441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985880700072X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":114,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S088985880700072X"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2007.06.001","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acquired Platelet Dysfunction","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2007.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}